Vecuronium Bromide for Injection 10 mg*, *1mg/mL when reconstituted to 10 mL Lyophilized, 10 x 10 mg vials, Rx only, Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway Halol-389 350, Gujarat, India. Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 NDC 47335-931-40 [vial] NDC 47335-931-44 [carton]
Published January 16, 2019 · Recall initiated: January 3, 2019
Summary
FDA records drug Class I recall D-0372-2019, published January 16, 2019 and initiated January 3, 2019. Recalling firm: Sun Pharmaceutical Industries, Inc.; Status: Terminated; Reported quantity: 12,534 cartons, 125,340 vials; Lot: Lot #: JKS0443A, JKS0444A, JKS0477A, EXP 03/2019. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter: Foreign matter identified as glass detected in Vecuronium Bromide for Injection.
What to do
Voluntary: Firm initiated · Letter
Get an email if VECURONIUM BROMIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- VECURONIUM BROMIDE
- Manufacturer
- Sun Pharmaceutical Industries, Inc.
- Distributor
- Nationwide in the USA
- UPC
- 0347335932447
- Lot
- Lot #: JKS0443A, JKS0444A, JKS0477A, EXP 03/2019
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAVecuronium Bromide for Injection, 20mg, 10 Single-Dose Vials per carton, Sterile, Rx Only, Mfd. for MeithealNovember 4, 2026
- FDAVecuronium Bromide for Injection, 10mg, 10 Single-Dose Vials per carton, Sterile, Rx Only, Mfd. for MeithealNovember 4, 2026
- FDACeftriaxone for Injection USP, 1 g, packaged in a) one Single Use Vial (NDC 68180-633-01) and b) 10 Single UseJanuary 16, 2019
- FDACefdinir for Oral Suspension USP, 125mg/5mL, packaged in a) 60mL (NDC 68180-722-20), b)100mL (NDCJanuary 16, 2019
- FDACeftriaxone for Injection USP, 500 mg, packaged in a) one Single Use Vial (NDC 68180-622-01) and b) 10 SingleJanuary 16, 2019
- FDACefdinir for Oral Suspension USP, 250mg/5mL, packaged in a) 60mL (NDC 68180-723-20), b)100mL (NDCJanuary 16, 2019
Questions about this recall
Was Vecuronium Bromide for Injection 10 mg*, *1mg/mL when reconstituted to 10 mL Lyophilized, 10 x 10 mg vials, Rx only, Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway Halol-389 350, Gujarat, India. Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 NDC 47335-931-40 [vial] NDC 47335-931-44 [carton] recalled?
Yes. FDA published recall D-0372-2019 on January 16, 2019. Reported hazard: Presence of Particulate Matter: Foreign matter identified as glass detected in Vecuronium Bromide for Injection.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: VECURONIUM BROMIDE. UPC: 0347335932447.